Mayer EL - Search Results

1

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update.

Andre F, Ismaila N, Allison KH, Barlow WE, Collyar DE, Damodaran S, Henry NL, Jhaveri K, Kalinsky K, Kuderer NM, Litvak A, Mayer EL, Pusztai L, Raab R, Wolff AC, Stearns V. Andre F, et al. Among authors: mayer el. J Clin Oncol. 2022 Jun 1;40(16):1816-1837. doi: 10.1200/JCO.22.00069. Epub 2022 Apr 19. J Clin Oncol. 2022. PMID: 35439025

2

Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer.

Mayer EL, Carey LA, Burstein HJ. Mayer EL, et al. Breast Cancer Res. 2007;9(5):110. doi: 10.1186/bcr1755. Breast Cancer Res. 2007. PMID: 17888189 Free PMC article.

3

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.

Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A. Partridge AH, et al. J Clin Oncol. 2008 Feb 1;26(4):556-62. doi: 10.1200/JCO.2007.11.5451. Epub 2008 Jan 7. J Clin Oncol. 2008. PMID: 18180462

4

Weighing a dose-dense option for adjuvant chemotherapy and trastuzumab in early-stage breast cancer.

Mayer EL, Burstein HJ. Mayer EL, et al. J Clin Oncol. 2008 Mar 10;26(8):1198-200. doi: 10.1200/JCO.2007.14.8734. J Clin Oncol. 2008. PMID: 18323544 No abstract available.

5

SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer.

Mayer EL, Dhakil S, Patel T, Sundaram S, Fabian C, Kozloff M, Qamar R, Volterra F, Parmar H, Samant M, Burstein HJ. Mayer EL, et al. Ann Oncol. 2010 Dec;21(12):2370-2376. doi: 10.1093/annonc/mdq260. Epub 2010 May 23. Ann Oncol. 2010. PMID: 20497961 Free article. Clinical Trial.

6

Advances in targeting SRC in the treatment of breast cancer and other solid malignancies.

Mayer EL, Krop IE. Mayer EL, et al. Clin Cancer Res. 2010 Jul 15;16(14):3526-32. doi: 10.1158/1078-0432.CCR-09-1834. Clin Cancer Res. 2010. PMID: 20634194 Review.

7

Congestive heart failure risk in patients with breast cancer treated with bevacizumab.

Choueiri TK, Mayer EL, Je Y, Rosenberg JE, Nguyen PL, Azzi GR, Bellmunt J, Burstein HJ, Schutz FA. Choueiri TK, et al. Among authors: mayer el. J Clin Oncol. 2011 Feb 20;29(6):632-8. doi: 10.1200/JCO.2010.31.9129. Epub 2011 Jan 4. J Clin Oncol. 2011. PMID: 21205755

8

A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer.

Mayer EL, Baurain JF, Sparano J, Strauss L, Campone M, Fumoleau P, Rugo H, Awada A, Sy O, Llombart-Cussac A. Mayer EL, et al. Clin Cancer Res. 2011 Nov 1;17(21):6897-904. doi: 10.1158/1078-0432.CCR-11-0070. Epub 2011 Sep 8. Clin Cancer Res. 2011. PMID: 21903773 Clinical Trial.

9

Breast cancer survivors' perceptions of survivorship care options.

Mayer EL, Gropper AB, Neville BA, Partridge AH, Cameron DB, Winer EP, Earle CC. Mayer EL, et al. J Clin Oncol. 2012 Jan 10;30(2):158-63. doi: 10.1200/JCO.2011.36.9264. Epub 2011 Dec 12. J Clin Oncol. 2012. PMID: 22162585 Free PMC article.

10

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.

Carey LA, Rugo HS, Marcom PK, Mayer EL, Esteva FJ, Ma CX, Liu MC, Storniolo AM, Rimawi MF, Forero-Torres A, Wolff AC, Hobday TJ, Ivanova A, Chiu WK, Ferraro M, Burrows E, Bernard PS, Hoadley KA, Perou CM, Winer EP. Carey LA, et al. Among authors: mayer el. J Clin Oncol. 2012 Jul 20;30(21):2615-23. doi: 10.1200/JCO.2010.34.5579. Epub 2012 Jun 4. J Clin Oncol. 2012. PMID: 22665533 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page